APOGEE THERAPEUTICS TO HOST CONFERENCE CALL TO REPORT INTERIM RESULTS FROM THE PHASE 1B TRIAL OF APG777 IN PATIENTS WITH MILD-TO-MODERATE ASTHMA AND 2026 ANTICIPATED MILESTONES ON JANUARY 6, 2026

Reuters · 5d ago

Please log in to view news